Use this site to access recordings and presentations from National Conferences
Autism Society records most keynote and concurrent sessions at their annual conferences. You can see and hear those recordings by purchasing full online access, or individual recordings.
3613
Oxidative Stress & Autism: A Roadmap for Effective Treatment
Friday, July 11, 2008: 10:45 AM-12:00 PM
Sun Ballroom B (Gaylord Palms Resort & Convention Center)
This workshop will cover Pfeiffer Treatment Center's effective biomedical approaches involving prescribed and individualized nutrient therapy - vitamins, minerals, and amino acids - to treat the person's system to help direct treatment. Past and new research findings of Health Research Institute (the reseach and development arm of the organization) will also be discussed including the effects of oxidative stress and low metallothionein activity in ASD.
Recent research has shown that oxidative stress is a dominant factor in autism-spectrum disorders (ASD). There are many different genetic defects that can predispose a child to ASD by weakened protection against oxidative stress, rendering the brain vulnerable to toxic metals., viruses and other environmental insults. The net result can be destruction of brain cells, incomplete maturation of the brain, and onset of autism. The harmful effects of oxidative stress on brain development, methylation, sulfur chemistry, the G.I., tract, protein digestion, and immune function will be discussed.
In 2000, Health Research Institute (HRI) and Pfeiffer Treatment Center (PTC) in Warrenville, Illinois, USA, discovered that diminished metallothionein protein (MT) activity is a distinctive feature of autism. This abnormality is associated with severe oxidative stress, impaired brain development, and extreme sensitivity to toxic metals and other environmental substances. HRI has developed a MT-promotion therapy that is used in conjunction with special diets and other biochemical treatments.
New research findings at PTC include (a) increased oxidative damage to vascular tissue; (b) depressed metallothionein in red blood cells, and (c) abnormal hormone chemistry. In collaboration with the U.S. Department of Energy Argonne National Laboratory and the University of Maryland, PTC has obtained the world’s first direct measurements of elements in brain tissues from persons with autism and in control groups. The results provide strong evidence of abnormal metal metabolism in autism. Advanced therapies for eliminating toxic metals, healing the blood/brain and intestinal barriers, and enhancing developments of new brain cells and synapses will be presented, along with an oxidative stress model of autism. More information can be found on PTC’s website: www.hriptc.org.
Learning Objectives:
- Learn how oxidative stress is a dominant factor in ASD and the many different genetic defects that can predispose a child to ASD by weakened protection against oxidative stress, rendering the brain vulnerable to toxic metals, viruses and other environmental insults. Harmful effects of oxidative stress occur in brain development, methylation, sulfur chemistry, the gastrointestinal tract, protein digestion and immune function.
- Learn advanced therapies for eliminating toxic metals, healing the blood/brain and intestinal barriers, and enhancing developments of new brain cells and synapses with an oxidative stress model of autism.
Content Area: Medicine and Research
Presenter:
Lewis Allen, M.D., FAAP
Pediatrician
Health Research Institute/Pfeiffer Treatment Center